Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Products>This Product

MaxDiscovery™ Human TRAIL/TNFSF10 ELISA Test Kit

Product Description
The MaxDiscovery™ Human TRAIL/TNFSF10 ELISA Test Kit is designed for quantitative determination of the concentration of human TRAIL/TNFSF10 in serum, plasma, and cell culture supernatant. TNF-related apoptosis-inducing ligand (TRAIL), a tumor necrosis factor superfamily (TNFSF) member designated TNFSF10, is a 281 amino acid protein which lacks a signal peptide. It is a Type II transmembrane protein consisting 3 domains, a glycosylated C-terminal extracellular domain, a transmembrane domain, and a short N-terminal cytoplasmic domain. Like other members of the TNFSF, TRAIL also exists in a soluble form. It has a broad expression pattern in fetal and adult tissues and variably expressed in tumor cell lines. Both cell-surface and soluble TRAIL induce apoptosis in a variety of lymphoid and non-lymphoid tumor cell lines. These effects are mediated through binding TRAIL receptors 1 and 2 (TRAIL R1 and TRAIL R2). Since TRAIL is capable of preferentially inducing apoptosis in tumor cells over normal cells, it has become an exciting prospect as a cancer pharmaceutical.
Product MaxDiscovery™ Human TRAIL/TNFSF10 ELISA Test Kit
Company BIOO Scientific - Product Directory
Price Request a quote
More Information View company product page
Catalog Number 2133-02
Quantity 1 x 96 wells
Company Logo

BIOO Scientific - Product Directory
3913 Todd Lane Suite 312 Austin, TX 78744, USA

Tel: +1 512-707-8993
Fax: +1 512-707-8122

Scientific News
Drug Target for Triple-Negative Breast Cancer Found
A team of researchers led by UC San Francisco scientists has identified a new drug target for triple-negative breast cancer.
Smartphone Laboratory Detects Cancer
Researchers develop low-cost, portable laboratory on a smartphonecapable of analysing multiple samples simultaneously.
First Entirely 3D-printed Organ-on-a-Chip with Integrated Sensors
New approach to manufacturing may allow researchers to rapidly design organs-on-chips that match the properties of a specific disease or individual patient's cells.
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
Untangling a Cause of Memory Loss in Neurodegenerative Diseases
The mouse study identifies a possible therapeutic target for a family of disorders.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Stiffening a Blow to Cancer Cells
Researchers develop a way to predict how a tumor tissue's physical properties affect its response to chemotherapy drugs.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos